Wells Pharmacy Network (“WPN”) is voluntarily recalling all sterile human and veterinary products prepared between February 22, 2016 and September 14, 2016, and that remain within expiry (list below) due to the Food and Drug Administration’s (“FDA”) concern over a lack of sterility assurance.
Administration of a drug product intended to be sterile that has microbial contamination may result in infections that may be serious and life-threatening.
The recalled products were used for a variety of indications. NO VIAL OR PORTION OF ANY LOT OF THESE MEDICATIONS HAS BEEN FOUND TO BE NON STERILE. All recalled products have a label that includes the name Wells Pharmacy Network, logo, drug name, and expiration date. If unsure, Customers can call the pharmacy to determine if their product is on the list. To date, no adverse events have been reported.
WPN takes the utmost care to ensure patient safety. All patients and providers that received any sterile compounded products prepared between February 22, 2016 and September 14, 2016, and that remain within expiry, should take the following actions:
- Discontinue use of the products;
- Quarantine any unused product until further instructions are received on how to return the product; and
- Contact WPN at the Quality hotline at (800) 794-2360 Monday through Friday, between 9:00 am and 6:00 pm EST or email at WPNQuality@wellsrx.com to discuss the return of any unused sterile product.
Customers with questions regarding this recall can contact WPN at the Quality hotline at (800) 794-2360 Monday through Friday between 9:00 am and 6:00 pm EST or email at WPNQuality@wellsrx.com. Customers should contact their physician, healthcare provider, or veterinarian if they have experienced any problems that may be related to using these products. Providers who have dispensed any sterile products prepared between February 22, 2016 and September 14, 2016 to a patient(s) for use outside of the provider’s office should contact the patient(s) to whom product was dispensed and advise the patient(s) of this recall.
Adverse reactions or quality problems experienced with the use of these products in animals may be reported to FDA in the following ways:
This recall is being conducted with the knowledge of and in cooperation with the FDA.
Wells Pharmacy Network specializes in “wellness, anti-aging, weight management, urology, ophthalmology, and veterinary compounding solutions.”
List of VETERINARY products to be recalled:
| HISTRELIN ACETATE, LYOPHILIZED 5.5MG INJECTABLE |
04062016@6 |
| PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE |
04082016@7 |
| DETOMIDINE HCL/XYLAZINE (20ML) 10MG/10MG/ML INJECTABLE |
04272016@94 |
| MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE |
05022016@11 |
| ESTRADIOL CYPIONATE 5MG/ML INJECTABLE |
05092016@12 |
| GLUCOSAMINE SULFATE 20% INJECTABLE |
05102016@6 |
| PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE |
05112016@3 |
| PENTOSAN SODIUM POLYSULFATE 250MG/ML INJECTABLE |
05112016@8 |
| METHOCARBAMOL 100MG/ML INJECTABLE |
05272016@3 |
| MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE |
05272016@5 |
| PENTOSAN SODIUM POLYSULFATE 250MG/ML INJECTABLE |
06142016@47 |
| PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE |
06152016@1 |
| MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE |
06202016@2 |
| METHOCARBAMOL 100MG/ML INJECTABLE |
06222016@7 |
| MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE |
06232016@27 |
| ESTRONE AQUEOUS 5MG/ML INJECTABLE |
06272016@29 |
| ESTRADIOL CYPIONATE 5MG/ML INJECTABLE |
06282016@79 |
| ESTRONE AQUEOUS 5MG/ML INJECTABLE |
06292016@5 |
| PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE |
07072016@7 |
| CYCLOSPORINE (A) OIL SOLUTION – (10ML) 2% OPHTHALMIC |
07142016@35 |
| PHENYLEPHRINE HCL – (5ML) 1MG/ML (0.1%) INJECTABLE |
07202016@44 |
| ESTRADIOL CYPIONATE 5MG/ML INJECTABLE |
08022016@13 |
| CYCLOSPORINE (A) OIL SOLUTION – (10ML) 2% OPHTHALMIC |
08022016@20 |
| PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE |
08022016@27 |
| DETOMIDINE HCL/XYLAZINE (20ML) 10MG/10MG/ML INJECTABLE |
08022016@70 |
| ESTRONE AQUEOUS 5MG/ML INJECTABLE |
08022016@8 |
| FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE |
08052016@47 |
| FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE |
08092016@57 |
| FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE |
08112016@7 |
| ESTRONE AQUEOUS 5MG/ML INJECTABLE |
08182016@7 |
| MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE |
08222016@18 |
For a complete list, including human medications involved in this recall, click here.
